- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05537649
Glycemic Responses of an Innovative Oat Porridge (GREAT)
September 8, 2022 updated by: Kristin Verbeke, KU Leuven
The aim of this study is to investigate whether enzymatic modification of starch in a food product using amylomaltase induces a lower glycemic response in healthy subjects compared to its unmodified counterpart.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A single-blind, randomized, cross-over study design will be applied.
During each of the two study visits, healthy participants will consume an oatmeal porridge.
One porridge will be treated will amylomaltase to modify the molecular structure of starch while the other porridge will serve as a control (unmodified counterpart).
Blood glucose measurements will be taken postprandially at regular time points.
Study Type
Interventional
Enrollment (Actual)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- KU Leuven
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Body mass index (BMI) range 18.5 - 25.0 kg/m2 at screening visit
- Fasting whole blood glucose values < 6.3 mmol/L
- Regular diet with 3 meals a day (at least 5 times a week)
- Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigators on the basis of medical history
- Willingness to maintain habitual diet, physical activity pattern, and body weight throughout the trial and refrain from smoking for 12 h prior to each visit
- Willingness to abstain from alcohol consumption and to avoid vigorous physical activity for 24 h prior to study visits.
- Adequate level of understanding spoken and written English
- Willingness to provide informed consent to participate in the study
Exclusion Criteria:
- Failure to meet any one of the inclusion criteria
- Recent participation in any clinical trial (< 90 days)
- Pregnant or lactating in the period of the study
- Known history of AIDS, hepatitis, diabetes mellitus (Type I and II), cardiovascular disease, any pathology (or recent surgical event) of the gastrointestinal system or any current metabolic or endocrine disease
- Alcohol consumption of > 14 standard drinks for women and > 21 standard drinks for men per week
- Celiac disease or gluten intolerance
- Use of medications known to influence carbohydrate metabolism, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids the last 4 weeks before the screening visit
- Use of antibiotics during the last three months
- Reported slimming or medically prescribed diet
- Unwillingness or inability to comply with the experimental procedures and to follow the safety guidelines
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Oatmeal porridge
Cold-stored oatmeal porridge (38 g oats) and stored for 24 h at 4 degrees Celsius
|
Investigation of the impact of enzymatic modification of the molecular structure of starch by amylomaltase on the postprandial glycemic responses of an oatmeal porridge.
|
Active Comparator: Oatmeal porridge treated with amylomaltase
Cold-stored oatmeal porridge (38 g oats) treated with 30 enzyme units/g oats of amylomaltase and stored for 24 h at 4 degrees Celsius
|
Investigation of the impact of enzymatic modification of the molecular structure of starch by amylomaltase on the postprandial glycemic responses of an oatmeal porridge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glucose response
Time Frame: up to 3 hours
|
incremental area under the curve of blood glucose after oat porridge consumption
|
up to 3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glucose response
Time Frame: up to 3 hours
|
peak rise of the blood glucose after oat porridge consumption
|
up to 3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 23, 2021
Primary Completion (Actual)
October 8, 2021
Study Completion (Actual)
October 8, 2021
Study Registration Dates
First Submitted
September 8, 2022
First Submitted That Met QC Criteria
September 8, 2022
First Posted (Actual)
September 13, 2022
Study Record Updates
Last Update Posted (Actual)
September 13, 2022
Last Update Submitted That Met QC Criteria
September 8, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- S64889
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postprandial Glycemic Responses
-
KU LeuvenCompletedPostprandial Glycemic ResponsesBelgium
-
PepsiCo Global R&DDSM Nutritional Products, Inc.Completed
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
PepsiCo Global R&DCompletedGlycemic | Insulinemic | Subjective Hunger ResponsesCanada
-
PepsiCo Global R&DCompletedGlycemic, Insulinemic, Subjective Appetite ResponsesCanada
-
Wageningen UniversityCompletedGlucose Metabolism | Postprandial Glucose ResponsesNetherlands
-
Cambridge GlycoscienceCompletedPostprandial Glycemic ResponseCanada
-
San Diego State UniversityRecruitingPostprandial Hyperglycemia | Postprandial Glycemic Response | Postprandial InsulinUnited States
-
University Hospital, Basel, SwitzerlandCompletedGastrointestinal Hormones | Glycemic Control | Appetite | Satiation | Reward Responses | Emotional StateSwitzerland
-
University College DublinActive, not recruitingGlucose Intolerance | Healthy Subjects | Postprandial Hyperglycemia | Glycemic Control | Diabetes Mellitus RiskIreland
Clinical Trials on Oatmeal porridge
-
PepsiCo Global R&DDSM Nutritional Products, Inc.Completed
-
PepsiCo Global R&DDSM Nutritional Products, Inc.Completed
-
Purdue UniversityCompletedObesity | Diabetes Mellitus, Type 2 | Appetitive BehaviorUnited States
-
PepsiCo Global R&DCompletedGlycemic ResponseCanada
-
Purdue UniversityBaylor College of MedicineCompletedObesity and Other Hyperalimentation
-
Purdue UniversityBaylor College of MedicineCompletedMalnutrition, Child
-
Purdue UniversityUnited States Agency for International Development (USAID)Not yet recruiting
-
University of ManitobaPepsiCo Global R&DCompletedNormal Body Weight | NormoglycemicCanada
-
Vanderbilt University Medical CenterCompletedCardiovascular Diseases | ObesityUnited States